The ai² Futures Lab program pairs multidisciplinary student teams with Lokahi Therapeutics leadership to evaluate emerging assets, explore strategic pathways, and develop market-informed ...

MATAWAN, N.J. & MOSCOW, Idaho--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (APUS) (“Apimeds”) today announced the expansion of its ai² Futures Lab™ program through a new collaboration with the ...

MATAWAN, N.J. & MOSCOW, Idaho--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Futures Lab™ program through a new ...

Lōkahi Therapeutics today announced the participation of the University of Georgia’s Student Industry Fellows Program in its ai² (actual intelligence) Futures Lab program for the Spring 2026 semester.

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) ...